While most of these cytokines were similarly modulated in MS and healthy donors (Figure 1A–C), we found that the expression of IL-21 was significantly higher in MS compared to healthy donors (Figure 1B), indicating a possible role for this cytokine in Th17-related MS pathogenesis. This evidence concerns the gene IL21 and myeloid sarcoma.